Showing results (81-90 of 926) with videos related to
Sort By:
Pageof 93
Journal of Neurochemistry|April 1, 1990
Alpha 1-adrenergic receptor mediates arachidonic acid release in spinal cord neurons independent of inositol phospholipid turnoverR Y Kanterman, C C Felder, D E Brenneman, et al.Brain Research|January 20, 1992
Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonistJ R Glowa, L V Panlilio, D E Brenneman, et al.Journal of Molecular Neuroscience : MN|January 1, 1994
Inhibition of human neuroblastoma growth by a specific VIP antagonistG Lilling, Y Wollman, M N Goldstein, et al.Endocrinology|July 19, 2001
IGF-I as a mediator of VIP/activity-dependent neurotrophic factor-stimulated embryonic growthS J Servoss, S J Lee, G Gibney, et al.Annals of the New York Academy of Sciences|February 24, 2001
A novel VIP responsive gene. Activity dependent neuroprotective proteinI Gozes, R Zamostiano, A Pinhasov, et al.Cancer|October 12, 2001
A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell linesE Gelber, R Granoth, M Fridkin, et al.The Journal of Clinical Investigation|July 15, 1997
Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brainP Gressens, S Marret, J M Hill, et al.Neuroscience|August 28, 1999
Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growthJ M Hill, S J Lee, D A Dibbern, et al.Proceedings of the National Academy of Sciences of the United States of America|May 15, 1993
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growthT W Moody, F Zia, M Draoui, et al.Annals of the New York Academy of Sciences|February 17, 2000
Vasoactive intestinal peptide regulates embryonic growth through the action of activity-dependent neurotrophic factorJ M Hill, G W Glazner, S J Lee, et al.Pageof 93